Robert Flint is hospital pharmacist and clinical pharmacologist in the Erasmus MC Sophia Children’s Hospital with a focus on the intensive care neonatology and obstetrics. Besides patient care, his research aims to determine optimal drug dosages for the most vulnerable premature born infants and during pregnancy. This has led to multiple descriptions of the pharmacokinetic profile of currently used drugs in (preterm) neonates, dose-finding exercised relating PK with PD, and a large ongoing randomised controlled drug trial. As an editorial board member of the Dutch pediatric drug formulary, Robert has short connections to implement these findings in clinical practice.
